Results 191 to 200 of about 1,105,809 (304)

History of Pediatric Oncology in Germany [PDF]

Klinische Pädiatrie, 2001
openaire   +2 more sources

Access to an mHealth Tool for Symptom Management in Pediatric Oncology Care: Triangulation Study. [PDF]

JMIR Form Res
Höök A, Forsgren E, Björk M, Castor C, Nordh E, Nilsson S.   +5 more
europepmc   +1 more source

Beyond Nature's Blueprint: Macrocyclic Peptides Containing Unnatural Amino Acids in Therapeutic Development

Angewandte Chemie, EarlyView.
Strategic incorporation of unnatural amino acids transforms macrocyclic peptides into drug‐like molecules capable of engaging challenging targets. These building blocks enhance stability, permeability, and bioavailability, accelerating the development of next‐generation peptide therapeutics.
Krishna K. Sharma, Komal Sharma, Anku Sharma, Kamya Rao, Rahul Jain, Brett VanVeller   +5 more
wiley   +1 more source

Parent Experiences Accessing Inpatient Clinical Notes on a Pediatric Oncology Service. [PDF]

Hosp Pediatr
Kieren MQ, Lee-Miller C, Smith CA, Brown R, Limjoco JJ, McArdle K, Uhing A, Veit A, Kelly MM.   +8 more
europepmc   +1 more source

Persistent Interleukin‐18 Fuels Expansion of CD38+HLA‐DR+CD8+ T Cells in Still Disease and Macrophage Activation Syndrome

Arthritis &Rheumatology, EarlyView.
Objective Still disease (SD) is an autoinflammatory disorder characterized by remarkably high interleukin‐18 (IL‐18) levels. Increasing evidence suggests that adaptive immunity also contributes to its pathogenesis, particularly in refractory courses. Macrophage activation syndrome (MAS), one of SD's most severe complications, is associated with further
Greta Rogani, Remco G. A. Erkens, Alejandra Bodelón, Tim R. Mocking, Marein T. M. Putmans, Freya M. C. H. Huijsmans, Lyanne J. P. M. Sijbers, Aafke M. De Ligt, Maurice J. H. Van Haaren, Rianne C. Scholman, Noël M. M. Dautzenberg, Joyce I. Meesters‐Ensing, Martina Rossano, Laura Porretti, Stefan Nierkens, Francesca S. Minoia, Sebastiaan J. Vastert, Jorg van Loosdregt   +17 more
wiley   +1 more source

Diagnostic Uncertainty and Continuity in Pediatric Oncology: A Caregiver's Perspective. [PDF]

J Patient Exp
AlRoomi AS.
europepmc   +1 more source

Pediatric Oncology [PDF]

British Journal of Cancer, 1981
openaire   +1 more source

Effect of developmental changes on pharmacokinetics of drugs used in the treatment of infant acute lymphoblastic leukaemia—A comprehensive review

British Journal of Clinical Pharmacology, EarlyView.
While the event‐free survival (EFS) of children treated for acute lymphoblastic leukaemia (ALL) has improved greatly in the last decades, the EFS for patients diagnosed with ALL before the age of one is still under 50%. This outcome further decreases when infants have a rearrangement in the gene encoding histone‐lysine N‐methyltransferase 2A (KMT2A ...
Tirsa de Kluis, Leiah J. Brigitha, Lidwien M. Hanff, Alwin D. R. Huitema, Inge M. van der Sluis, Meta H. M. Diekstra   +5 more
wiley   +1 more source

Factors Associated with Autopsy Consent in Pediatric Oncology: A 10-Year Review. [PDF]

Curr Oncol
Weaver MS, Liang J, Jalfon R, Li Y, Cohen AD, Johnson LM.   +5 more
europepmc   +1 more source